| dc.contributor.author | Galluzzi, L. | |
| dc.contributor.author | Chan, T. A. | |
| dc.contributor.author | Kroemer, Guido | |
| dc.contributor.author | Wolchok, J. D. | |
| dc.contributor.author | López Soto, Alejandro | |
| dc.date.accessioned | 2019-01-30T07:58:07Z | |
| dc.date.available | 2019-01-30T07:58:07Z | |
| dc.date.issued | 2018 | |
| dc.identifier.citation | Science Translational Medicine, 10(459), p. eaat7807- (2018); doi:10.1126/scitranslmed.aat7807 | |
| dc.identifier.issn | 1946-6234 | |
| dc.identifier.uri | http://hdl.handle.net/10651/49975 | |
| dc.format.extent | p. eaat7807- | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Science Translational Medicine, 10 | |
| dc.rights | © 2018 Galluzzi et al. | |
| dc.source | Scopus | |
| dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85053503895&doi=10.1126%2fscitranslmed.aat7807&partnerID=40&md5=ec3de4d8786c69f75db2f96322442a89 | |
| dc.title | The hallmarks of successful anticancer immunotherapy | eng |
| dc.type | journal article | |
| dc.identifier.doi | 10.1126/scitranslmed.aat7807 | |
| dc.relation.publisherversion | http://dx.doi.org/10.1126/scitranslmed.aat7807 | |
